Document Detail


Identification of thrombin-like activity in ovarian cancer associated ascites and modulation of multiple cytokine networks.
MedLine Citation:
PMID:  21833453     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Blood coagulation cascades can be activated by different mechanisms and to different levels in cancer patients. In a study conducted on the transcriptional profile of epithelial ovarian cancer patients a number of possible links between coagulation and inflammation have been suggested and we and others have reported that, in addition to its central role in blood coagulation and haemostasis, thrombin is a powerful regulator of inflammatory responses. Here, we report that thrombin- like activities were present in the malignant ascites of patients with ovarian carcinoma. Malignant ascites significantly enhanced the release of cytokines/chemokines, which have been previously shown to support tumour progression, such as interleukin (IL)-6, IL-1β, CCL2 and CXCL8, in human peripheral blood mononuclear cells of healthy volunteers. Interestingly, ascites enhanced the release of the anti-inflammatory cytokine IL-10 and inhibited the production of interferon-γ and IL-12. The presence of the anticoagulant antithrombin reversed IL-12 inhibition induced by ascites in human monocytes. Finally, the use of thrombin and of the specific thrombin receptor (PAR) agonist peptides, TFLLRN and AYGPK, suggests that IL-12 inhibition is thrombin-specific and related to PAR-1, but not to PAR-4. These findings underline the tight relationship between the coagulation pathway, where thrombin is the key enzyme, and cytokine modulation, including IL-12 inhibition, which is a critical feature of the tumour microenvironment, and may represent a powerful strategy used by tumours to escape immune surveillance.
Authors:
A Naldini; E Morena; D Belotti; F Carraro; P Allavena; R Giavazzi
Related Documents :
10497863 - Can we learn from the pathogenetic strategies of group a hemolytic streptococci how tis...
12594893 - Prevention and treatment of multiple organ dysfunction syndrome: lessons learned and fu...
11707863 - Historical perspective on the use of retinoids in cutaneous t-cell lymphoma (ctcl).
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-11
Journal Detail:
Title:  Thrombosis and haemostasis     Volume:  106     ISSN:  0340-6245     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-8-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7608063     Medline TA:  Thromb Haemost     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Dr. Antonella Naldini, Department of Physiology, University of Siena, Via Aldo Moro, 53100 Siena, Italy, Tel.: +39 0577 234212, Fax: +39 0577 234219, E-mail: Naldini@Unisi.it.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebran...
Next Document:  Cardiac troponin testing and the simplified Pulmonary Embolism Severity Index. The SWIss Venous Thro...